| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 05/18/2012 | WO2012007978A3 Fermented soya based mixture comprising isoflavones- aglicones, equol and lunasil, process for the preparation and uses thereof in food, medical and cosmetic fields |
| 05/18/2012 | CA2817407A1 Non-replicating probiotic micro-organisms protect children against gastrointestinal infections |
| 05/18/2012 | CA2815749A1 Ibat inhibitors for the treatment of liver diseases |
| 05/18/2012 | CA2815698A1 A pharmaceutical combination comprising an ibat inhibitor and a bile acid binder |
| 05/18/2012 | CA2814195A1 Crystal of 6,7-unsaturated-7-carbamoyl morphinan derivative and method for producing the same |
| 05/17/2012 | US20120122987 Treatment of disorders associated with g protein-coupled receptor 35 (gpr35) |
| 05/17/2012 | US20120122985 Tranexamic Acid Formulations |
| 05/17/2012 | US20120122982 Use of pufas to treat nerve damage |
| 05/17/2012 | US20120122977 Substituted amino bisphenyl pentanoic acid derivatives as NEP inhibitors |
| 05/17/2012 | US20120122940 Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas |
| 05/17/2012 | US20120122933 Compounds |
| 05/17/2012 | US20120122930 1H-Benzimidazole-5-Carboxamides As Anti-Inflammatory Agents |
| 05/17/2012 | US20120122924 Nampt inhibitors |
| 05/17/2012 | US20120122921 Process for making modulators of cystic fibrosis transmembrane conductance regulator |
| 05/17/2012 | US20120122919 Pharmaceutical composition combining tenatoprazole and a histamine h2-receptor antagonist |
| 05/17/2012 | US20120122917 Method For Treatment Of HIV And Diseases Of Immune Dysregulation |
| 05/17/2012 | US20120122915 Crystalline forms of palonosetron hydrochloride |
| 05/17/2012 | US20120122907 Novel Pyrazole Derivatives and their use as Positive Allosteric Modulators of Metabotropic Glutamate Receptors |
| 05/17/2012 | US20120122904 Solid forms of (s)-2-amino-3-(4-(2-amino-6-((r)-1-(4-chloro-2-(3-methyl-1h-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)pyrimidin-4-yl)phenyl)propanoic acid |
| 05/17/2012 | US20120122894 Inhibitors of bruton's tyrosine kinase |
| 05/17/2012 | US20120122891 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 05/17/2012 | US20120122889 Small molecule inhibitors of necroptosis |
| 05/17/2012 | US20120122886 Thiadiazole-substituted arylamides as p2x3 and p2x2/3 antagonists |
| 05/17/2012 | US20120122879 Compounds useful as protein kinase inhibitors |
| 05/17/2012 | US20120122855 Benzoxazines, benzothiazines, and related compounds having nos inhibitory activity |
| 05/17/2012 | US20120122852 Tricyclic n-heteroaryl-carboxamide derivatives containing a benzimidazole unit, method for preparing same and their therapeutic use |
| 05/17/2012 | US20120122850 Biphenyl compounds useful as muscarinic receptor antagonists |
| 05/17/2012 | US20120122842 Nampt and rock inhibitors |
| 05/17/2012 | US20120122827 Novel derivatives of cholest-4-en-3-one oxime, pharmaceutical compositions containing them and preparation method |
| 05/17/2012 | US20120122826 Novel quinuclidine derivatives and medicinal compositions containing the same |
| 05/17/2012 | US20120122824 Reduction of Side Effects From Aromatase Inhibitors Used for Treating Breast Cancer |
| 05/17/2012 | US20120122785 Combination of a leucine source and an omega- 3 unsaturated fatty acid source for use in the treatment of hypercalcaemia |
| 05/17/2012 | US20120122784 Novel calcium sensing receptor modulating compounds and pharmaceutical use thereof |
| 05/17/2012 | US20120122781 Peptide ligands of somatostatin receptors |
| 05/17/2012 | US20120122776 Dpp-iv inhibitors for treatment of diabetes in pediatric patients |
| 05/17/2012 | US20120122765 Compounds and related methods for manipulating parp-1-dependent cell death |
| 05/17/2012 | US20120122764 Substituted carbamoylcycloalkyl acetic acid derivatives as nep |
| 05/17/2012 | US20120122763 Novel tetrahydrocarbazole derivatives as ligands of g-protein coupled receptors |
| 05/17/2012 | US20120122762 186 Human Secreted Proteins |
| 05/17/2012 | US20120121741 Water soluble defructosylated pea extract, and use thereof as a prebiotic agent |
| 05/17/2012 | US20120121724 Film comprising therapeutic agents |
| 05/17/2012 | US20120121698 Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same |
| 05/17/2012 | US20120121689 Small interfering rna delivery |
| 05/17/2012 | US20120121668 Compositions for oral adminstration of active principles requiring masking of taste |
| 05/17/2012 | US20120121664 Gastric Acid Secretion Inhibiting Composition |
| 05/17/2012 | US20120121655 Chewable Formulation Comprising Alginate, Bicarbonate And Carbonate |
| 05/17/2012 | US20120121622 Biodegradable immunomodulatory formulations and methods for use thereof |
| 05/17/2012 | US20120121621 Synergistic prebiotic compositions |
| 05/17/2012 | US20120121601 Mammalian receptor proteins; related reagents and methods |
| 05/17/2012 | US20120121584 Monoclonal Antibodies Against Extracellular Loops of C5aR |
| 05/17/2012 | US20120121582 Modulators Of EphA2 And Ephrina1 For The Treatment Of Fibrosis-Related Disease |
| 05/17/2012 | US20120121578 Methods of using immunoglobulin aggregates |
| 05/17/2012 | US20120121564 Use of selected lactic acid bacteria for reducing infantile colic |
| 05/17/2012 | US20120121563 Specialized nutritional formula for adult patients with gastrointestinal intolerance containing probiotics |
| 05/17/2012 | US20120121562 Nutritional composition for breast-fed infants or pets with probiotics and selected nutrients |
| 05/17/2012 | US20120121556 Methods of using regenerative cells to promote wound healing |
| 05/17/2012 | US20120121554 Hmg-coa secondary metabolites and uses thereof |
| 05/17/2012 | US20120121541 3,5-disubstituted and 3,5,7-trisubstituted-3h-oxazolo and 3h-thiazolo[4,5-d]pyrimidin-2-one compounds and prodrugs thereof |
| 05/17/2012 | US20120121530 Vasoprotective and cardioprotective antidiabetic therapy |
| 05/17/2012 | US20120121503 Inhibition Of CD69 For Treatment Of Inflammatory Conditions |
| 05/17/2012 | US20120121502 Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof |
| 05/16/2012 | EP2453009A1 Methods of organ regeneration |
| 05/16/2012 | EP2452950A1 Antibody having anti-cancer activity |
| 05/16/2012 | EP2452690A1 Carboxymethylarginine production inhibitor and collagen denaturation inhibitor |
| 05/16/2012 | EP2452680A1 Acid pump antagonist for treatment of diseases associated with abnormal gastrointestinal movement |
| 05/16/2012 | EP2451462A1 Inhibiting inflammation with milk oligosaccharides |
| 05/16/2012 | EP2451299A1 Methods and compositions for treating thyroid-related medical conditions with reduced folates |
| 05/16/2012 | EP2451298A1 Product for the storage of freeze-dried lactic acid bacteria mixed with a powder for an oral rehydration solution |
| 05/16/2012 | EP2451276A1 Methods of treating pdnv and ponv with extended release ondansetron compositions |
| 05/16/2012 | EP2254573B1 Compositions comprising phytoestrogens selective for estrogen beta receptor and dietary fibres |
| 05/16/2012 | EP2142200B1 Homeopathy-based formulation |
| 05/16/2012 | EP1864665B1 Immunosuppressive agent comprising a heterocyclic compound as active ingredient |
| 05/16/2012 | CN202219033U A device employing traditional Chinese medicine to treat complicating diseases of gallbladder channel and spleen channel |
| 05/16/2012 | CN202218985U Traditional Chinese medicine pulp for treating stomach meridian tissue diseases and package |
| 05/16/2012 | CN102459577A 适合临床应用于免疫介导性疾病的、具有增强型抑制功能的调节性t细胞的体外扩增方法 Suitable for clinical application of immune-mediated diseases, with enhanced suppression function of regulatory t-cells in vitro amplification methods |
| 05/16/2012 | CN102459247A 作为醛固酮合酶抑制剂的苯并噁唑酮衍生物 As aldosterone synthase inhibitors benzoxazole derivatives |
| 05/16/2012 | CN102459215A 3-(4-aminophenyl)-2-furancarboxylic acid derivative and pharmaceutically acceptable salt thereof |
| 05/16/2012 | CN102459185A 新型甲状腺激素β受体激动剂 Novel thyroid hormone receptor β agonists |
| 05/16/2012 | CN102458449A Combination of (a) a phosphoinositide 3-kinase inhibitor and (b) an antidiabetic compound for use in the treatment of proliferative diseases |
| 05/16/2012 | CN102458447A Reference picture lists for 3dv |
| 05/16/2012 | CN102458443A 细胞周期蛋白依赖性激酶抑制剂及使用方法 Cyclin-dependent kinase inhibitors and methods of use |
| 05/16/2012 | CN102458428A Nfat signal inhibitor and calcineurin inhibitor |
| 05/16/2012 | CN102458419A Use of a composition for the treatment of mucositis |
| 05/16/2012 | CN102458417A Enhancer of activity of nucleic acid analogue |
| 05/16/2012 | CN102458407A Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors |
| 05/16/2012 | CN102458400A Serotonin 5-ht3 receptor antagonists for use in the treatment of lesional vestibular disorders |
| 05/16/2012 | CN102453713A HULC siRNA and use of HULC siRNA in preparation of drugs for treatment of liver cancer |
| 05/16/2012 | CN102453657A Method for preparing astragalus medicinal liquor |
| 05/16/2012 | CN102451474A Antitumor effect, implementation method and usage of miRNA (micro-ribonucleic acid) |
| 05/16/2012 | CN102451472A Application of minimal heterodimer partner in blood lipid regulation |
| 05/16/2012 | CN102451470A Oxymatrine phosphatide compound and preparation method and application thereof |
| 05/16/2012 | CN102451451A Preparation method of traditional Chinese medicinal prescription for treating peptic ulcer |
| 05/16/2012 | CN102451448A Preparation method for costusroot, clove and cassia bark powder |
| 05/16/2012 | CN102451445A Chinese medicinal preparation for treating cholecystitis |
| 05/16/2012 | CN102451443A Recipe for treating gynecological inflammation and preparation process of recipe |
| 05/16/2012 | CN102451440A Chinese medicinal formula for treating acute gastroenteritis |
| 05/16/2012 | CN102451432A Preparation method of Chinese medicinal prescription for treating fatty liver |
| 05/16/2012 | CN102451426A Preparation method of Chinese medicine oral liquid with function of promoting digestion |
| 05/16/2012 | CN102451425A Chinese patent drug preparation for treating hepatitis and preparation method thereof |
| 05/16/2012 | CN102451412A Preparation method of Chinese medicinal prescription for treating virus hepatitis |